Eng

Canada speeding up production of medical supplies

XINHUA
發布於 2020年03月31日20:25

Customers wearing face masks shop at a supermarket in Mississauga, Ontario, Canada, March 24, 2020. (Photo by Zou Zheng/Xinhua)

"We know that the demand for critical equipment and supplies will grow in the coming weeks, so we need a sustainable, stable supply of these products. And that means making them at home and we're optimistic that they will be available in the coming weeks," Canadian Prime Minister Justin Trudeau said.

廣告(請繼續閱讀本文)

OTTAWA, March 31 (Xinhua) -- Canadian Prime Minister Justin Trudeau announced Tuesday that his government is allocating two billion Canadian dollars (1.4 billion U.S. dollars) to buy more protective personal equipment against the COVID-19 spread.

Trudeau said his government has signed deals with three Canadian companies Thornhill Medical, Medicom and Spartan Bioscience to make ventilators, surgical masks, test kits and other medical supplies over the coming weeks to cope with the country's rapidly increasing number of COVID-19 cases.

"We know that the demand for critical equipment and supplies will grow in the coming weeks, so we need a sustainable, stable supply of these products. And that means making them at home and we're optimistic that they will be available in the coming weeks," Trudeau said at his daily press conference in Ottawa.

廣告(請繼續閱讀本文)

A traveler arrives at Union Station in Toronto, Canada, on March 30, 2020. (Photo by Zou Zheng/Xinhua)

Earlier this month, Trudeau announced to provide monetary support to manufacturers that can retool their assembly lines to make ventilators, masks and other personal protective gear, and to help those already making such products quickly scale up manufacturing capacity.

廣告(請繼續閱讀本文)

The government has already shifted Canada's entire industrial policy to focus on the COVID-19 fight. It includes reprioritizing existing innovation and research programs and working on agreements with industry to produce more diagnostic testing products and other disease tracking technology.

Canadian International Trade Minister Mary Ng also announced earlier this month that the government temporarily eliminated tariffs and taxes on all goods imported by public health authorities in the country.

As of 2 p.m. Tuesday Canada Eastern Time, there were 8,467 confirmed COVID-19 cases and 95 deaths in the country, according to CTV News, which has been tracking the number of COVID-19 cases in Canada.  ■

更多 Eng 相關文章

Guangzhou becomes latest Chinese city to ease home-buying restrictions
XINHUA
Update: China, Equatorial Guinea elevate ties
XINHUA
Acer Debuts Premium Chromebook Plus Laptops for Productivity and Gaming with Google AI built-in
PR Newswire (美通社)
EyesOnSci | Shenzhou-18 crew completes first spacewalk
XINHUA
Guangzhou, Shenzhen become latest Chinese cities to ease home-buying restrictions
XINHUA
Alpha X to Make Its Debut at SEMICON SEA 2024 with Cutting-Edge AI-Driven Manufacturing Solutions
PR Newswire (美通社)
HanAll Biopharma Signs Licensing Agreement with Turn Biotechnologies to Develop Novel Treatments for Eye and Ear Diseases
PR Newswire (美通社)
More optimized housing policies in China address diverse demands, raise market expectations
XINHUA
Xi Focus: Xi stresses promoting high-quality, sufficient employment
XINHUA
ICZOOM & WeBank signed the Supply Chain Finance Strategic Cooperation Agreement
PR Newswire (美通社)
Latest Therapeutic Choice for Multiple Myeloma Patients
PR Newswire (美通社)
Xinhua News | Shenzhou-18 crew members complete first spacewalk
XINHUA
SocialFi Infrastructure OpenSocial Protocol Raises $5M to Fuel the Growth of SocialFi Super Apps, with $15M Ecosystem Fund Backed by EVG
PR Newswire (美通社)
Zheng cruises into French Open 2nd round as Cornet retires in tears
XINHUA
China-Japan-South Korea leaders' meeting held in Seoul
XINHUA
Qinling Mountains shrouded in swirling clouds
XINHUA
Mideast in Pictures: Rafah after Israeli airstrike
XINHUA
Hamas says no ceasefire negotiations with Israel after Rafah attack: source
XINHUA
China-Japan-South Korea business summit pledges efforts to promote cooperation
XINHUA
Ovarian tissue transplantation is gaining ground for fertility preservation in young and old, with potential to offset adverse effects of menopause
PR Newswire (美通社)
SichuanMosaics | A glance into Kingdom of Azalea in SW China's Sichuan
XINHUA
indent, inc., Operator of Largest Creative Platform Nola, Appoints Yui Tsutsumi as Chief "Isekai" Officer, or Independent Director
PR Newswire (美通社)
Hello Group Inc. Announces Unaudited Financial Results for the First Quarter of 2024
PR Newswire (美通社)
"Bleach: Brave Souls" to be Released on the Nintendo Switch & Xbox with Thousand-Year Blood War Zenith Summons: Gravitation Featuring New Versions of Masaki and Isshin to Begin May 31
PR Newswire (美通社)
Leading Indonesian Fintech JULO Accelerates Insurance Inclusion with Financial Inclusion through JULO Protect Plus
PR Newswire (美通社)
Peak season arrives for Tibetan antelope migration to Hoh Xil
XINHUA
From Saint Petersburg to Tianjin, a Russian girl pursuing Chinese culture
XINHUA
Tencent Deploys AI to Help Researchers Decipher Hidden Meanings in Oracle Bone Scripts
PR Newswire (美通社)
DFI Showcases Cutting-Edge Smart Transportation Solutions with AI and ESG Commitments at Computex 2024
PR Newswire (美通社)
Mainland's Taiwan affairs official meets former KMT chairperson
XINHUA
Red Cross China spends 97 mln USD on public welfare in 2023
XINHUA
Update: Shenzhou-18 crew members complete first spacewalk
XINHUA
China's top legislator holds talks with speaker of Indonesia's House of Representatives
XINHUA
Computex '24: Join Us to Unlock Infinite Possibilities in AI
PR Newswire (美通社)
Our Towns | Unlock unique, intangible cultural heritages at water town in E China
XINHUA
GLOBALink | President Xi welcomes Equatorial Guinean counterpart Obiang
XINHUA
China's joint drills around Taiwan island are resolute punitive response to provocation for "Taiwan independence": FM spokesperson
XINHUA
GIGABYTE Pioneers AI PC Market with AI Innovations and Leading Silicon Partnerships
PR Newswire (美通社)
Rege Nephro CO., Ltd. Announces Patient Enrollment for Phase II Clinical Trial of Tamibarotene for ADPKD
PR Newswire (美通社)